Denke, C.
Jaschinski, U.
Riessen, R.
Bercker, S.
Spies, C.
Ragaller, M.
Weiss, M.
Dey, K.
Michalsen, A.
Briegel, J.
Pohrt, A.
Sprung, C. L.
Avidan, A.
Hartog, C. S. http://orcid.org/0000-0003-1098-9775
,
Funding for this research was provided by:
Charité - Universitätsmedizin Berlin
Article History
Received: 14 April 2022
Revised: 9 August 2022
Accepted: 30 August 2022
First Online: 28 September 2022
Declarations
:
: C. Denke, U. Jaschinski, R. Riessen, S. Bercker, C. Spies, M. Ragaller, M. Weiss, K. Dey, A. Michalsen, J. Briegel, A. Pohrt, C. L. Sprung, A. Avidan, and SepNetCriticalCareTrialsGroup—Ethicus2 study group declare that they have no competing interests. C. S. Hartog reports funding grants paid to her institution from the Innovations Funds of the German Federal Joint Committee (FKZ 01VSF19020, FKZ 01VSF17010) and the European Society of Intensive Care Medicine (ESICM; 2018–2021).
: For this article no studies with human participants or animals were performed by any of the authors. All studies mentioned were in accordance with the ethical standards indicated in each case.